The Hamburg Parkinson day-clinic: a new treatment concept at the border of in- and outpatient care

Journal of Neural Transmission
Odette FründtCarsten Buhmann

Abstract

To close a gap between inpatient and outpatient care, the Hamburg Parkinson day-clinic (HPDC) has been developed as a new and comprehensive, individual, interdisciplinary type of treatment for patients with complex Parkinsonian syndromes (PS). First, we describe the HPDC concept, in which a multi-professional medical team of PD specialists provide a time- and personnel-wise intensive care and focuses on the patients' individual deficits and resources. Second, we present short-term outcome results of the first 184 PS patients enrolled during 16 months including objective clinical motor and non-motor scores taken before and after participation in the HPDC, as well as the patients' subjective evaluation of the HPDC. Out of the 184 patients with PS (aged 39-88 years with Hoehn and Yahr scores between 1.0 and 4.5), 169 were diagnosed to have Parkinson disease (PD). HPDC treatment led to improvement of all applied motor (UPDRS III, AIMS) and non-motor (BDI-II, MoCA, PDNMS, PDSS-2, King's PD Pain Scale, QUIP, PDQ-39) scores (p < 0.05) indicating benefits for akinesia, tremor, dyskinesia, cognition, sleep, pain, impulse control disorders and quality of life. Patients evaluated HPDC care positively with values from 1.39 to 2.79 ("very g...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·V PetoR Greenhall
Dec 1, 1996·Journal of Personality Assessment·A T BeckW Ranieri
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Jul 23, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine A GrossetDonald G Grosset
Mar 21, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kallol Ray ChaudhuriCharles W Olanow
Nov 26, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzUNKNOWN Movement Disorder Society UPDRS Revision Task Force
May 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubValerie Voon
Oct 6, 2009·Current Protocols in Neuroscience·Joel S Perlmutter
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderKallol Ray Chaudhuri
Dec 3, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubAndrew Siderowf
Jan 1, 2012·The Neurohospitalist·Odinachi Oguh, Aleksandar Videnovic
Jun 9, 2016·Fortschritte der Neurologie-Psychiatrie·C BuhmannD Woitalla
Oct 12, 2016·Acta Neurologica Scandinavica·M NeriusG Doblhammer
Jan 27, 2017·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Silvia SchiavolinMatilde Leonardi
Feb 6, 2017·Journal of Neural Transmission·Ole-Bjørn Tysnes, Anette Storstein
Mar 1, 2017·Journal of Neural Transmission·Günter U HöglingerWolfgang H Jost
Jun 13, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Nataliya Titova, K Ray Chaudhuri
Jun 22, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Shuai ZhangFeng Chen
Aug 15, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A B DeutschländerZ K Wszolek
Aug 15, 2017·International Review of Neurobiology·Nataliya Titova, K Ray Chaudhuri
Aug 15, 2017·International Review of Neurobiology·Nataliya Titova, K Ray Chaudhuri
Sep 26, 2017·Movement Disorders Clinical Practice·Leonardo AlmeidaNikolaus R McFarland
Jun 13, 2018·Psychotherapy and Psychosomatics·Andrea W M EversJohn M Kelley

❮ Previous
Next ❯

Citations

May 18, 2020·Journal of Clinical Medicine·Tino PrellMartin Wolz
Jun 2, 2020·Expert Review of Neurotherapeutics·Sarah C LidstoneAnthony E Lang
Jul 1, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Roopa RajanCarsten Eggers
Aug 14, 2020·Journal of Clinical Medicine·Tino PrellTobias Mai
Feb 23, 2021·Current Neurology and Neuroscience Reports·Miriam R RaffertyJillian MacDonald

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
Ariel B NeikrugSonia Ancoli-Israel
Movement Disorders : Official Journal of the Movement Disorder Society
Kapil Sethi
© 2022 Meta ULC. All rights reserved